GeneHealth - Your precision medicine

Immunodeficiency 36

Disease Details

Family Health Simplified

Buy Membership

Description: Immunodeficiency_36 is a rare genetic disorder characterized by severe immunodeficiency, leading to increased susceptibility to infections and impaired immune response due to mutations in the PIK3CD gene.
Type: Immunodeficiency 36 is an autosomal recessive disorder.
Signs And Symptoms: Immunodeficiency characterized by its identifier "36" is not a standard nomenclature used in medical terminology. However, if you are referring to a specific set of signs and symptoms associated with a particular immunodeficiency disorder, please provide more details or context. Generally, immunodeficiency disorders, regardless of their specific classification, often present with:

- Frequent infections
- Infections that are unusually severe or difficult to treat
- Recurrent respiratory infections, such as bronchitis or pneumonia
- Chronic diarrhea
- Skin rashes
- Delayed growth and development (in children)
- Autoimmune disorders

If you can provide more context or clarify the specific immunodeficiency disorder you are referring to, a more tailored response can be given.
Prognosis: "Immunodeficiency_36" is not a recognized term for any known disease or condition. It might be a placeholder or a specific code used in a research or clinical context.

If you provide more specific details or confirm if it relates to a specific type of immunodeficiency, I can offer more accurate information regarding prognosis and other aspects.
Onset: Immunodeficiency_36, also known as Immunodeficiency 36, typically has its onset in early childhood. The term "nan" seems unclear in this context; it might be an error or an abbreviation that is not commonly recognized in medical terminology related to this disease.
Prevalence: Information about the prevalence of Immunodeficiency_36 (IMD36) is not readily available, which suggests it is likely a rare condition. Because it is a form of primary immunodeficiency, the prevalence can vary widely depending on the specific population and the availability of diagnostic resources.
Epidemiology: Immunodeficiency_36, or IMD36, is a rare primary immunodeficiency disorder caused by mutations in the IRF8 gene. This condition impacts the immune system, making individuals more susceptible to infections. Due to its rarity, comprehensive epidemiological data on IMD36 is limited. Typically, such disorders are studied through case reports and small patient cohorts rather than large population-based studies. Cases have been documented across various geographic locations, but they are sporadic and mainly identified through genetic testing and immunological assessment.
Intractability: Immunodeficiency_36, also known as Activated PI3K Delta Syndrome (APDS), is considered intractable as it is a genetic disorder with no definitive cure. Management typically focuses on treating infections, immune modulation, and possibly stem cell transplantation in severe cases.
Disease Severity: Immunodeficiency 36 (IMD36) is a severe primary immunodeficiency disorder characterized by a significant reduction in NK (natural killer) cells and impaired cytotoxic T-cell function. This condition leads to increased susceptibility to severe viral infections and other opportunistic infections due to the compromised immune system. Disease severity can vary but is generally severe due to the critical role of NK and cytotoxic T-cells in immune defense.
Healthcare Professionals: Disease Ontology ID - DOID:0111949
Pathophysiology: Immunodeficiency 36, also known as B-cell immunodeficiency, is a rare genetic disorder. The pathophysiology involves mutations in genes responsible for the development and function of B cells, a type of white blood cell crucial for the adaptive immune response. These mutations hinder the production of functional B cells, leading to a compromised ability to produce antibodies. This impairment makes individuals more susceptible to recurrent infections and may result in an inadequate response to vaccinations.
Carrier Status: Immunodeficiency 36 is an autosomal recessive disorder. Individuals who have one copy of the mutated gene and one normal gene are considered carriers. Carriers typically do not show symptoms but can pass the mutated gene to their offspring. When two carriers have a child, there is a 25% chance the child will inherit both mutated copies and be affected by the disease, a 50% chance the child will be a carrier like the parents, and a 25% chance the child will inherit two normal copies of the gene.
Mechanism: Immunodeficiency-36, also known as Combined Immunodeficiency (CID) due to DOCK8 deficiency or DOCK8 deficiency syndrome, is an autosomal recessive disorder characterized by severe combined immunodeficiency (SCID).

**Mechanism:**
The condition is caused by loss-of-function mutations in the DOCK8 gene. This gene encodes a protein crucial for various cellular functions, including immune cell migration and survival.

**Molecular Mechanisms:**
1. **Gene Mutation:** Mutations in the DOCK8 gene lead to truncated or dysfunctional DOCK8 protein, impairing its functions.
2. **Immune Cell Dysfunction:** DOCK8 is involved in actin cytoskeleton reorganization. The defective protein disrupts lymphocyte (T and B cells) and natural killer (NK) cell morphology and migration, compromising the immune response.
3. **Impaired Signal Transduction:** DOCK8 acts as a guanine nucleotide exchange factor (GEF) for small GTPases. Mutations affect signaling pathways critical for immune cell activation, proliferation, and survival.
4. **Increased Apoptosis:** The defective DOCK8 protein leads to higher rates of apoptosis in T cells and other leukocytes, further weakening the immune system.

These molecular disruptions result in increased vulnerability to various infections and impaired immune responses, hallmarks of immunodeficiency-36.
Treatment: It appears there might be confusion or lack of context regarding "immunodeficiency_36." This term isn't standard in medical literature. Immunodeficiencies are often categorized as primary (genetic) or secondary (acquired). It's crucial to specify the exact condition to provide accurate treatment information. For some primary immunodeficiencies, treatment might include bone marrow transplant, immunoglobulin replacement, or gene therapy. Secondary immunodeficiencies often involve treating the underlying cause, such as managing HIV/AIDS with antiretrovirals. For precise advice, consulting a healthcare professional with detailed patient information is essential.
Compassionate Use Treatment: Immunodeficiency_36 (IMD36), also known as BENTA disease (B cell expansion with NF-κB and T cell anergy), is a rare immunodeficiency disorder. Here are some options for compassionate use, off-label, or experimental treatments that have been explored or considered:

1. **Hematopoietic Stem Cell Transplantation (HSCT)**: This procedure has been tried as a potential curative approach. HSCT replaces the dysfunctional immune system with a healthy one and is considered in severe cases.

2. **Targeted Therapies**: There are experimental treatments targeting the NF-κB pathway, which is abnormally activated in BENTA disease. Research into specific inhibitors and modulators is ongoing.

3. **Immunoglobulin Replacement Therapy**: This off-label treatment can help manage recurrent infections by providing patients with the necessary antibodies they lack.

4. **Anti-CD20 Monoclonal Antibodies**: Rituximab, an anti-CD20 monoclonal antibody, is sometimes used off-label to reduce B cell levels and control symptoms.

5. **Gene Therapy**: This experimental approach aims to correct the underlying genetic defect causing BENTA disease. While still in the research phase, preclinical studies show promise.

These treatments require careful consideration by medical professionals, and access to them might be limited to clinical trials or specialized programs.
Lifestyle Recommendations: For individuals with immunodeficiency, lifestyle recommendations generally include:

1. **Healthy Diet:** Consume a balanced diet rich in fruits, vegetables, whole grains, lean protein, and healthy fats to support overall health and immune function.
2. **Regular Exercise:** Engage in moderate physical activity to enhance cardiovascular health and improve mood while avoiding overexertion.
3. **Adequate Sleep:** Aim for 7-9 hours of quality sleep per night to help the body recover and maintain a healthy immune system.
4. **Good Hygiene:** Practice regular hand washing, dental hygiene, and reasonable precautions to avoid infections, such as staying away from sick individuals.
5. **Stress Management:** Employ techniques such as meditation, yoga, or deep breathing exercises to manage stress effectively.
6. **Regular Medical Checkups:** Maintain regular follow-ups with healthcare providers and adhere to prescribed treatments.
7. **Vaccinations:** Stay up-to-date with recommended vaccinations, including annual flu shots, to prevent infections.
8. **Avoiding Risks:** Stay away from environments or activities that increase the risk of infections, such as crowded places during outbreaks.

Specific recommendations can vary based on the type and severity of the immunodeficiency, so it's essential to follow personalized guidelines from healthcare professionals.
Medication: Immunodeficiency_36, also known as DOCK8 deficiency, is a rare primary immunodeficiency disorder caused by mutations in the DOCK8 gene. Management generally includes:

1. **Antibiotics and Antiviral Prophylaxis**: To prevent infections.
2. **Immunoglobulin Replacement Therapy**: To boost the immune system.
3. **Antifungal Medications**: To prevent and treat fungal infections.
4. **Vaccinations**: Certain non-live vaccines may be recommended.
5. **Hematopoietic Stem Cell Transplant (HSCT)**: Considered a potential cure, but the approach depends on patient-specific factors.

Consultation with a specialist is recommended for personalized treatment.
Repurposable Drugs: Currently, there is no specific disease listed as "immunodeficiency_36" in established medical literature or databases. It might refer to a particular subtype within a broader category of primary immunodeficiencies. If it pertains to a specific condition, more context or specific identifiers would be necessary to provide accurate information. Please consult detailed medical resources or a healthcare professional for precise information.
Metabolites: Immunodeficiency_36, also known as Hyper IgE Syndrome (HIES), is linked to defective signaling in the STAT3 pathway. The primary metabolite associated with this condition is an elevated level of Immunoglobulin E (IgE). Other metabolites are not typically characterized in routine clinical diagnosis for this condition. If you need more detailed metabolic information, specific biochemical profiling would be necessary.
Nutraceuticals: There are no specific nutraceuticals that are universally recommended for the treatment of immunodeficiency. Nutraceuticals generally refer to products derived from food sources that provide extra health benefits, including vitamins, minerals, herbs, and other botanicals. For individuals with immunodeficiency, a healthcare professional may suggest certain vitamins like vitamin C, vitamin D, and zinc to support the immune system, but these should be tailored to an individual's specific needs and medical condition.

Regarding "nan," if this pertains to nanotechnology within the context of treating immunodeficiency, research is ongoing in using nanomaterials for targeted drug delivery, vaccine development, and immunomodulation. These nanotechnology-based approaches offer potential for more effective treatments by precisely targeting affected cells and tissues, reducing side effects, and enhancing the body's natural immune responses.
Peptides: For immunodeficiency_36 (also known as ID-36), specific peptide information and involvement in treatment, diagnosis, or disease mechanism are not widely characterized. The term "peptides" broadly refers to short chains of amino acids that may be involved in signaling, immune responses, or structural functions within proteins. Given the complexity of immunodeficiencies, peptides might play roles in modulating immune responses or could be investigated for therapeutic purposes. However, detailed and specific information pertinent to ID-36 would require focused research or context.

If "nan" refers to something else beyond the provided context, additional details would be necessary for a precise response.